Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
Vijay PotluriRadha K ShandilR GavaraGanesh SambasivamBrice CampoSergio WittlinShridhar NarayananPublished in: Malaria journal (2020)
FNDR-20123 may be a suitable candidate for the treatment of malaria, which can be further developed.